Tests of global haemostasis and their applications in bleeding disorders

Haemophilia

Volumn 16, Issue SUPPL. 5, 2010, Pages 85-92

  Nair, S C ^a   Dargaud, Y ^b,c   Chitlur, M ^d   Srivastava, A ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c University Lyon 1   (France)

^d CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Global; Haemophilia; Haemostasis; Heterogeneity; Phenotype; Thrombin

Indexed keywords

BLEEDING DISORDER; BLOOD CLOTTING TEST; CLOT WAVE FORM ANALYSIS; DISEASE SEVERITY; HEMOPHILIA A; HEMOSTASIS; HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBIN TIME; THROMBOCYTE POOR PLASMA; THROMBOELASTOGRAPHY;

HEMORRHAGIC DISORDERS; HEMOSTASIS; HUMANS; PARTIAL THROMBOPLASTIN TIME; PHENOTYPE; PROTHROMBIN TIME; THROMBELASTOGRAPHY; THROMBIN; THROMBIN TIME;

EID: 77955015786     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02304.x     Document Type: Review

References (37)

1. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in Adults. Mayo Clin Proc 2007, 82:864-73.
2. Langdell RD, Wagner RH, Brinkhous KM. Effect of anti-hemophilic factor on one stage clotting tests: a presumptive test for haemophilia and a simple one-stage anti-hemophilic assay procedure. J Lab Clin Med 1953, 41:637-47.
3. White GC, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 2001, 85:560.
4. Kay MA, Manno CS, Ragni MV. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with AAV vector. Nat Genet 2000, 24:257-61.
5. Dargaud Y, Beguin S, Lienhart A. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005, 93:475-80.
6. Jayandharan GR, Srivastava A. The phenotypic heterogeneity of severe haemophilia. Semin Thromb Hemost 2008, 34:128-41.
7. Turecek PL, Váradi K, Keil B. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb 2003, 33:16-22.
8. Ingerslev J, Poulsen LH, Sorensen B. Potential role of the dynamic properties of whole blood coagulation in assessment of dosage requirements in haemophilia. Haemophilia 2003, 9:348-52.
9. Braun PJ, Givens TB, Stead AG. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemost 1997, 78:1079-87.
10. Hemker HC, Giesen P, Al DieriR. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003, 33:4-15.
11. Al Dieri R, Peyvandi F, Santagostino E. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thromb Haemost 2002, 88:576-82.
12. Dargaud Y, Lienhart A, Meunier S. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia 2005, 11:552-8.
13. Besser M, Baglin C, Luddington R, van Hylckama Vlieg A, Baglin T. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin generation potential in a prospective cohort study. J Thromb Haemost 2008, 6:1720-5.
14. Dargaud Y, Luddington R, Gray E. Effect of standardisation and normalisation on imprecision of Calibrated automated thrombography (CAT): an international multicentre study. Br J Haematol 2007, 139:303-9.
15. Dargaud Y, Luddington R, Gray E. Standardisation of thrombin generation test - which reference plasma for TGT? An international multicentre study. Thromb Res 2010, 125:353-6.
16. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Haemost 2008, 34:612-34.
17. Dargaud Y, Negrier C. Thrombin generation testing in haemophilia comprehensive care centers. Haemophilia 2009, 16:223-230. Aug 27. [Epub ahead of print]
18. Spronk HMH, Dielis AWJH, Panova-Noeva M. Monitoring thrombin generation: is addition of corn trypsin inhibitor needed? Thromb Haemost 2009, 101:1156-62.
19. De Smedt E, Wagenvoord R, Hemker HC. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution. Thromb Haemost 2009, 101:165-170.
20. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004, 2:102-10.
21. Chitlur M, Warrier I, Rajpurkar M. Thromboelastography in children with coagulation factor deficiencies. Br J Haematol 2008, 142:250-6.
22. Trowbridge CC, Stammers AH, Ciccarelli N, Klayman M. Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review. J Extra Corpor Technol 2006, 38:254-9.
23. Young G, Blain R, Nakagawa P, Nugent DJ. Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastography. Haemophilia 2006, 12:598-604.
24. Nielsen VG, Cankovic L, Steenwyk BL. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered? Blood Coagul Fibrinolysis 2007, 18:35-9.
25. Urban MK, Beckman J, Gordon M, Urquhart B, Boachie-Adjei O. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine(Phila Pa 1976) 2001, 26:1152-6.
26. Ghosh K, Shetty S, Kulkarni B. Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients. Haemophilia 2007, 13:734-9.
27. Lak M, Scharling B, Blemings A. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram. Haemophilia 2008, 14:103-10.
28. Lovejoy AE, Reynolds TC, Visich JE. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 2006, 108:57-62.
29. Collyer TC, Gray DJ, Sandhu R, Berridge J, Lyons G. Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography Platelet Mapping. Br J Anaesth 2009, 102:492-8.
30. Johansson PI. Hemostatic strategies for minimizing mortality in surgery with major blood loss. Curr Opin Hematol 2009, 16:509-14.
31. Rivard GE, Kathleen Brummel K, Mann KG, Fan L, Hofer A, Cohen E. Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thromboelastography. J Thromb Haemos 2005, 3:2039-43.
32. Shima M, Matsumoto T, Fukuda K. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:c). Thromb Haemost 2002, 87:436-41.
33. Nair SC, Mammen J, Srivastava A, Singh S, Kavitha ML, Viswabandhya A. Clot curve analysis - another method to assess coagulation using coagulometer photo-optical data: clinical application and comparison with thrombin generation test. Haemophilia 2004, 10(S3):15. abs OS13
34. Kasuda S, Tanaka I, Shima M. Effectiveness of Factor VIII infusions in haemophilia A patients with high responding inhibitors. Haemophilia 2004, 10:341-6.
35. Shima M, Matsumoto T, Ogiwara K. New assays for monitoring haemophilia treatment. Haemophilia 2008, 14(S3):83-92.
36. Downey C, Kazmi R, Toh CH. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation. Br J Haematol 1997, 98:68-73.
37. Su Z, Braun PJ, Klemp KF, Baker KR, Thames EH, Ortel TL. Abnormal optical waveform profiles in coagulation assays from patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2002, 13:7-17.